These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 11680571

  • 1. Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model.
    Nikolova Z, Hof A, Baumlin Y, Hof RP.
    Transpl Immunol; 2001 Oct; 9(1):43-9. PubMed ID: 11680571
    [Abstract] [Full Text] [Related]

  • 2. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
    Nikolova Z, Hof A, Baumlin Y, Hof RP.
    Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
    [Abstract] [Full Text] [Related]

  • 3. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z, Hof A, Baumlin Y, Hof RP.
    Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
    [Abstract] [Full Text] [Related]

  • 4. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
    Schuurman HJ, Ringers J, Schuler W, Slingerland W, Jonker M.
    Transplantation; 2000 Mar 15; 69(5):737-42. PubMed ID: 10755519
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid allografts in apolipoprotein E-deficient mice.
    Matsumoto Y, Hof A, Baumlin Y, Hof RP.
    Transplantation; 2003 Oct 27; 76(8):1166-70. PubMed ID: 14578747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
    Hausen B, Boeke K, Berry GJ, Segarra IT, Christians U, Morris RE.
    J Heart Lung Transplant; 1999 Feb 27; 18(2):150-9. PubMed ID: 10194039
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B, Gummert J, Berry GJ, Christians U, Serkova N, Ikonen T, Hook L, Legay F, Schuler W, Schreier MH, Morris RE.
    Transplantation; 2000 Feb 27; 69(4):488-96. PubMed ID: 10708100
    [Abstract] [Full Text] [Related]

  • 11. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 27; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 12. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
    Quesniaux VF, Menninger K, Kunkler A, Vedrine C, Bernhard M, Hedinger R, Kraus G, Schuurman HJ.
    Transpl Immunol; 2000 Nov 27; 8(3):177-87. PubMed ID: 11147698
    [Abstract] [Full Text] [Related]

  • 13. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 14. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
    Hausen B, Boeke K, Berry GJ, Segarra I, Benet LZ, Christians U, Morris RE.
    Transplantation; 1999 Apr 15; 67(7):956-62. PubMed ID: 10221478
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.
    Hausen B, Boeke K, Berry GJ, Christians U, Schüler W, Morris RE.
    Ann Thorac Surg; 2000 Mar 15; 69(3):904-9. PubMed ID: 10750781
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME, Tejpal N, Qu X, Yu J, Okamoto M, Stepkowski SM, Kahan BD.
    Transplantation; 1998 Apr 15; 65(7):899-905. PubMed ID: 9565092
    [Abstract] [Full Text] [Related]

  • 17. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH, Milekhin V, Zhang H, Huang HZ.
    Acta Pharmacol Sin; 2003 Sep 15; 24(9):847-52. PubMed ID: 12956930
    [Abstract] [Full Text] [Related]

  • 18. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H, Hosiawa KA, Min W, Yang J, Zhang X, Garcia B, Ichim TE, Zhou D, Lian D, Kelvin DJ, Zhong R.
    J Immunol; 2003 Oct 01; 171(7):3823-36. PubMed ID: 14500684
    [Abstract] [Full Text] [Related]

  • 19. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD, Morris RE.
    Transplantation; 1993 Mar 01; 55(3):578-91. PubMed ID: 7681226
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of everolimus and cyclosporine A on intimal alpha-actin-positive cell dynamics of carotid allografts in mice.
    Matsumoto Y, Hof A, Baumlin Y, Müller M, Hof RP.
    Transplantation; 2004 Aug 15; 78(3):345-51. PubMed ID: 15316361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.